Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Payables: 2016-2025

Historic Payables for Mesoblast (MESO) over the last 10 years, with Jun 2025 value amounting to $19.1 million.

  • Mesoblast's Payables rose 169.90% to $19.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $48.8 million, marking a year-over-year decrease of 17.26%. This contributed to the annual value of $19.1 million for FY2025, which is 169.90% up from last year.
  • Latest data reveals that Mesoblast reported Payables of $19.1 million as of FY2025, which was up 169.90% from $7.1 million recorded in FY2024.
  • Mesoblast's 5-year Payables high stood at $23.1 million for FY2022, and its period low was $7.1 million during FY2024.
  • Its 3-year average for Payables is $15.4 million, with a median of $19.1 million in 2025.
  • Its Payables has fluctuated over the past 5 years, first crashed by 64.90% in 2024, then spiked by 169.90% in 2025.
  • Mesoblast's Payables (Yearly) stood at $19.6 million in 2021, then grew by 17.76% to $23.1 million in 2022, then declined by 12.71% to $20.1 million in 2023, then slumped by 64.90% to $7.1 million in 2024, then soared by 169.90% to $19.1 million in 2025.